SYVN1 and breast carcinoma: We explored the in vivo effects of HRD1 on the breast cancer chemoresistance by injecting MCF7/Tam cells stable overexpressing HRD1 or the corresponding controls into nude mice, respectively (Supplementary Figure 5).